| Literature DB >> 32319241 |
Ji Hyun Choi1, Jee Young Lee1, Jin Whan Cho2, Seong Beom Ko3, Tae Beom Ahn4, Sang Jin Kim5, Sang Myung Cheon6, Joong Seok Kim7, Yoon Joong Kim8, Hyeo Il Ma8, Jong Sam Baik9, Phil Hyu Lee10, Sun Ju Chung11, Jong Min Kim12, In Uk Song13, Han Joon Kim14, Young Hee Sung15, Do Young Kwon16, Jae Hyeok Lee17, Ji Young Kim18, Ji Sun Kim19, Ji Young Yun20, Hee Jin Kim21, Jin Yong Hong22, Mi Jung Kim3, Jinyoung Youn19, Ji Seon Kim23, Eung Seok Oh24, Hui Jun Yang25, Won Tae Yoon26, Sooyeoun You27, Kyum Yil Kwon28, Hyung Eun Park7, Su Yun Lee6, Younsoo Kim29, Hee Tae Kim30, Mee Young Park31.
Abstract
BACKGROUND ANDEntities:
Keywords: compulsive behavior; impulsive behavior; parkinson disease; rating scale; validation study
Year: 2020 PMID: 32319241 PMCID: PMC7174122 DOI: 10.3988/jcn.2020.16.2.245
Source DB: PubMed Journal: J Clin Neurol ISSN: 1738-6586 Impact factor: 3.077
Characteristics of the 136 patients included in this study
| Variable | Value |
|---|---|
| Age, years | 66.8±9.0 (39–85) |
| Sex, male | 65 (47.8) |
| Disease duration, months | 47.3±46.8 (1–252) |
| Total LED, mg/day | 654.8±473.4 (0–2250) |
| Agonist LED, mg/day | 107.5±149.7 (0–825) |
| H&Y stage | 2.1±0.7 (1–5) |
| UPDRS part I score | 2.0±2.0 (0–8) |
| UPDRS part II score | 7.8±6.0 (0–29) |
| UPDRS part III score | 20.2±11.0 (0–54.5) |
| K-MMSE score | 26.9±3.7 (4–30) |
| MoCA-K score | 22.6±5.0 (1–30) |
| K-MADS score | 10.3±9.6 (0–40) |
| K-PDQ39 summary index | 33.1±28.5 (0–123) |
| K-RBDQ score | 3.3±2.9 (0–13) |
Data are mean±SD (range) or n (%) values.
H&Y: Hoehn and Yahr, K-MADS: Korean Version of the Montgomery-Asberg Depression Scale, K-MMSE: Korean Version of the Mini Mental State Examination, K-PDQ39: Korean Version of the Parkinson's Disease Quality of Life-39, K-RBDQ: Korean Version of the Rapid-Eye-Movement Sleep-Behavior-Disorders Screening Questionnaire, LED: levodopa equivalent dose, MoCA-K: Korean Version of the Montreal Cognitive Assessment, UPDRS: Unified Parkinson's Disease Rating Scale.
Distribution of the K-QUIP-RS scores in the Parkinson's disease patients included in this study
| K-QUIP-RS domain | Mean±SD | Median (range) | ||
|---|---|---|---|---|
| Gambling | 0.3±1.3 | 0 (0–12) | 8 (5.9) | 1 (0.7) |
| Hypersexuality | 0.2±0.9 | 0 (0–7) | 13 (9.6) | 0 (0.0) |
| Buying | 0.2±0.8 | 0 (0–5) | 16 (11.8) | 0 (0.0) |
| Eating | 0.5±1.2 | 0 (0–8) | 28 (20.6) | 1 (0.7) |
| Hobbyism/punding | 1.1±2.6 | 0 (0–18) | 33 (24.3) | 6 (4.4) |
| DDS | 0.2±1.2 | 0 (0–10) | 6 (4.4) | NA |
| Summed score for ICD† | 1.2±2.7 | 0 (0–16) | 39 (28.7) | 5 (3.7) |
| Total K-QUIP-RS score | 2.5±5.0 | 0 (0–28) | 47 (34.6) | NA |
*Cutoffs from the original American Version of the QUIP-RS: gambling, ≥6; hypersexuality, ≥8; buying, ≥8; eating, ≥7; hobbyism/punding, ≥7; and summed score for ICD, ≥10, †Summed score for ICD domains includes gambling, hypersexuality, buying, and eating.
DDS: dopamine dysregulation syndrome, ICD: impulse-control disorder, K-QUIP-RS: Korean Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease Rating Scale, NA: not available.
Test–retest reliability of the K-QUIP-RS and coefficients for the correlations between the various domains and the total K-QUIP-RS score
| K-QUIP-RS domain | Guttman split-half coefficient | Spearman's rank correlation | |
|---|---|---|---|
| Gambling | 0.908 | 0.392 | <0.001 |
| Hypersexuality | 0.079 | 0.539 | <0.001 |
| Buying | 0.863 | 0.551 | <0.001 |
| Eating | 0.708 | 0.723 | <0.001 |
| Hobbyism/punding | 0.830 | 0.820 | <0.001 |
| DDS | 0.347 | 0.379 | <0.001 |
| Summed score for ICD | 0.726 | 0.887 | <0.001 |
| Total K-QUIP-RS score | 0.808 | - | - |
Summed score for ICD domains includes gambling, hypersexuality, buying, and eating.
DDS: dopamine dysregulation syndrome, ICD: impulse-control disorder, K-QUIP-RS: Korean Version of the Questionnaire for ImpulsiveCompulsive Disorders in Parkinson's Disease Rating Scale, rS: Spearman's rank correlation coefficient.
Fig. 1Correlations between the total score on the K-QUIP-RS and other clinical measures. (A) total LED (R2=0.078, p=0.019) and scores on the (B) K-MADS (R2=0.033, p=0.009), (C) K-PDQ39 SI (R2=0.052, p=0.009), and (D) K-RBDQ (R2=0.057, p=0.010). K-MADS: Korean Version of the Montgomery-Asberg Depression Scale, K-PDQ39: Korean Version of the Parkinson's Disease Questionnaire-39, K-QUIP-RS: Korean Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease Rating Scale, K-RBDQ: Korean Version of the Rapid-Eye-Movement Sleep-Behavior-Disorders Screening Questionnaire, LED: levodopa equivalent dose, SI: summary index.
Coefficients for the correlations between the K-QUIP-RS score and clinical variables
| Variable | Summed score for ICD | Total QUIP-RS score |
|---|---|---|
| Age | -0.063 | -0.160 |
| Disease duration | 0.044 | 0.077 |
| Total LED | 0.134 | 0.209* |
| Agonist LED | 0.117 | 0.181* |
| H&Y stage | 0.091 | 0.121 |
| UPDRS part I | 0.091 | 0.200* |
| Intellectual impairment | 0.114 | 0.133 |
| Thought disorder | 0.078 | 0.105 |
| Depression | 0.026 | 0.176* |
| Motivation/initiative | 0.152 | 0.239† |
| UPDRS part II | 0.114 | 0.214* |
| UPDRS part III | 0.058 | 0.084 |
| K-MMSE score | -0.133 | -0.132 |
| MoCA-K score | -0.028 | -0.044 |
| K-MADS score | 0.230** | 0.224† |
| K-PDQ39 summary index | 0.171* | 0.223† |
| Mobility | 0.110 | 0.160 |
| Activities of daily living | 0.139 | 0.171* |
| Emotional well-being | 0.145 | 0.213* |
| Stigma | 0.040 | 0.122 |
| Social support | 0.170* | 0.219* |
| Cognition | 0.259* | 0.273† |
| Communication | 0.238** | 0.264† |
| Bodily discomfort | 0.231** | 0.302† |
| K-RBDQ score | 0.216* | 0.220* |
Summed score for ICD domains includes gambling, hypersexuality, buying, and eating. Spearman's rank correlation test: *p<0.05, †p<0.01. H&Y: Hoehn and Yahr, ICD: impulse-control disorder, K-MADS: Korean Version of the Montgomery-Asberg Depression Scale, K-MMSE: Korean Version of the Mini Mental State Examination, K-PDQ39: Korean Version of the Parkinson's Disease Quality of Life-39, K-QUIP-RS: Korean Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease Rating Scale, K-RBDQ: Korean Version of the Rapid-Eye-Movement Sleep-Behavior-Disorders Screening Questionnaire, LED: levodopa equivalent dose, UPDRS: Unified Parkinson's Disease Rating Scale.